Seroprevalence of Anti-SARS-CoV-2 Antibodies among Outpatients in Southwestern Seoul, Korea
- PMID: 32830472
- PMCID: PMC7445312
- DOI: 10.3346/jkms.2020.35.e311
Seroprevalence of Anti-SARS-CoV-2 Antibodies among Outpatients in Southwestern Seoul, Korea
Abstract
Serosurveillance studies reveal the actual disease burden and herd immunity level in the population. In Seoul, Korea, a cross-sectional investigation showed 0.07% anti-severe acute respiratory syndrome coronavirus-2 antibody seropositivity among 1,500 outpatients of the university hospitals. Low seroprevalence reflects well-implemented social distancing. Serosurveillance should be repeated as the pandemic progresses.
Keywords: COVID-19; SARS-CoV-2; Seroepidemiology; Seroprevalence.
© 2020 The Korean Academy of Medical Sciences.
Conflict of interest statement
The authors have no potential conflicts of interest to disclose.
Figures


References
-
- World Health Organization. Population-based age-stratified seroepidemiological investigation protocol for coronavirus 2019 (COVID-19) infection. [Updated 2020]. [Accessed July 5, 2020]. https://www.who.int/publications/i/item/WHO-2019-nCoV-Seroepidemiology-2....
-
- Ministry of Health and Welfare (KR) Coronavirus disease-19, Republic of Korea. [Updated 2020]. [Accessed July 5, 2020]. http://ncov.mohw.go.kr/
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous